Evidence map›Paper›PMID 41124406›Full record

ArticleMemorias do Instituto Oswaldo Cruz2025

Concomitant immunity against superimposed homologous Echinostoma caproni infections in mice is mediated by interleuquin-25.

Paola Cociancic, Emma Fiallos, José Guillermo Esteban, Carla Muñoz-Antoli, Rafael Toledo

Abstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Susceptibility of mice to primaryFrontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paola CociancicUniversitat de València, Facultad de Farmacia y Ciencias de la Alimentación, Área de Parasitología, Departamento de Farmacia y Tecnología Farmacéutica y Parasitología, Valencia, Spain.
Emma FiallosUniversitat de València, Facultad de Farmacia y Ciencias de la Alimentación, Área de Parasitología, Departamento de Farmacia y Tecnología Farmacéutica y Parasitología, Valencia, Spain.
José Guillermo EstebanUniversitat de València, Facultad de Farmacia y Ciencias de la Alimentación, Área de Parasitología, Departamento de Farmacia y Tecnología Farmacéutica y Parasitología, Valencia, Spain.
Carla Muñoz-AntoliUniversitat de València, Facultad de Farmacia y Ciencias de la Alimentación, Área de Parasitología, Departamento de Farmacia y Tecnología Farmacéutica y Parasitología, Valencia, Spain.
Rafael ToledoUniversitat de València, Facultad de Farmacia y Ciencias de la Alimentación, Área de Parasitología, Departamento de Farmacia y Tecnología Farmacéutica y Parasitología, Valencia, Spain.ORCID http://orcid.org/0000-0003-2651-9794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Institute of Cancer Research (ICR) mouse-Echinostoma caproni model is used to study mechanisms generating resistance against intestinal helminths due to the development chronic primary infections with Th1 responses, and partial resistance to secondary infections.

objectivesThis study aimed to evaluate the generation of concomitant immunity against superimposed homologous E. caproni infection.

methodsChanges in cytokine expression and macrophages markers as a consequence of primary infection, superimposed infection and superimposed infection in anti (α)-interleuquin(IL)-25-treated mice were investigated by real-time polymerase chain reaction (PCR). Translocation and phosphorylation of STAT6 were studied by indirect immunofluorescence (IIF) on intestinal tissue sections. The IIF technique was also used to label M1 and M2 macrophages to confirm the activation pathways.

findingsPrimary E. caproni infections elicit partial resistance against homologous superimposed infections. The animal groups displayed distinct patterns in the expression of cytokines, macrophages markers and IL-13Rα2 as well as STAT6 phosphorylation in a process mediated by IL-25. Resistance appears to rely on the ability of to induce IL-13Rα2 upregulation. MAIN

conclusionsThe concomitant immunity is based the production of IL-25, rather than in the development of Th2 responses. Regarding the IL-25-dependent mechanisms responsible for concomitant immunity, the ability of IL-25 to induce IL-13Rα2 upregulation which serves to limit the production of other regulatory proteins such as Ym1 affecting the maintenance of mucosal homeostasis appears to be critical.

Indexed as

CytokinesEchinostomaEchinostomiasisInterleukin-17AnimalsDisease Models, AnimalFemaleMacrophagesMiceReal-Time Polymerase Chain ReactionSTAT6 Transcription FactorCytokinesInterleukin-17STAT6 Transcription Factor

Identifiers

PMID41124406
PMCPMC12543364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.